News and Trends 24 Aug 2022
Millions in funding and new board members for Belgian mRNA company
The mRNA technologies company eTheRNA has raised €39 million ($38.7 million) in series B2 financing. Belgium-based eTheRNA will use the money to expand investment in its integrated mRNA technology platform…